Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Mol Model ; 20(7): 2231, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24935104

ABSTRACT

AT1 receptor is an interesting biological target involved in several important diseases, such as blood hypertension and cardiovascular pathologies. In this study we investigated the main electrostatic and steric features of a series of AT1 antagonists related to hypertensive activity using structure and ligand-based strategies (docking and CoMFA). The generated 3D model had good internal and external consistency and was used to predict the potency of an external test set. The predicted values of pIC50 are in good agreement with the experimental results of biological activity, indicating that the 3D model can be used to predict the biological property of untested compounds. The electrostatic and steric CoMFA maps showed molecular recognition patterns, which were analyzed with structure-based molecular modeling studies (docking). The most and the least potent compounds docked into the AT1 binding site were subjected to molecular dynamics simulations with the aim to verify the stability and the flexibility of the ligand-receptor interactions. These results provided valuable insights on the electronic/structural requirements to design novel AT1 antagonists.


Subject(s)
Angiotensin II Type 1 Receptor Blockers/chemistry , Angiotensin II Type 1 Receptor Blockers/pharmacology , Antihypertensive Agents/chemistry , Antihypertensive Agents/pharmacology , Molecular Docking Simulation , Molecular Dynamics Simulation , Receptor, Angiotensin, Type 1/chemistry , Receptor, Angiotensin, Type 1/drug effects , Static Electricity , Angiotensin II Type 1 Receptor Blockers/metabolism , Antihypertensive Agents/metabolism , Binding Sites , Blood Pressure/drug effects , Computer-Aided Design , Drug Design , Ligands , Molecular Structure , Protein Binding , Protein Conformation , Quantitative Structure-Activity Relationship , Receptor, Angiotensin, Type 1/metabolism , Renin-Angiotensin System/drug effects
2.
PLoS One ; 9(1): e81301, 2014.
Article in English | MEDLINE | ID: mdl-24416129

ABSTRACT

Among several biological targets to treat AIDS, HIV integrase is a promising enzyme that can be employed to develop new anti-HIV agents. The aim of this work is to propose a mechanistic interpretation of HIV-1 integrase inhibition and to rationalize the molecular features related to the binding affinity of studied ligands. A set of 79 HIV-1 integrase inhibitors and its relationship with biological activity are investigated employing 2D and 3D QSAR models, docking analysis and DFT studies. Analyses of docking poses and frontier molecular orbitals revealed important features on the main ligand-receptor interactions. 2D and 3D models presenting good internal consistency, predictive power and stability were obtained in all cases. Significant correlation coefficients (r(2) = 0.908 and q(2)= 0.643 for 2D model; r(2)= 0.904 and q(2)= 0.719 for 3D model) were obtained, indicating the potential of these models for untested compounds. The generated holograms and contribution maps revealed important molecular requirements to HIV-1 IN inhibition and several evidences for molecular modifications. The final models along with information resulting from molecular orbitals, 2D contribution and 3D contour maps should be useful in the design of new inhibitors with increased potency and selectivity within the chemical diversity of the data.


Subject(s)
HIV Integrase Inhibitors/chemistry , HIV Integrase Inhibitors/pharmacology , Molecular Docking Simulation , Databases, Chemical , Inhibitory Concentration 50 , Ligands , Pyrrolidinones/chemistry , Pyrrolidinones/pharmacology , Quantitative Structure-Activity Relationship , Raltegravir Potassium , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL
...